Clinical trial · Observational
Current Management of Gastrointestinal Stromal Tumors (GIST) in the Region of Coquimbo
Outcomes of Surgical Treatment of Gastrointestinal Stromal Tumors in the IV Region of Chile
NCT00564265CI-TRIAL-00005352completedResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a retrospective analysis and description of the preferred diagnostic and treatment methods employed on GIST on the Region of Coquimbo from 2003 to 2008.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastrointestinal Stromal Tumors | Gastrointestinal Stromal Tumor | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Observation | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- GIST
- description
- GIST from all gastrointestinal origins: esophagus, stomach, duodenum, jejunum, ileum, colon and rectum
- interventionNames
- Other: Observation
Primary outcomes (1)
- measure
- Number of Patients Who Survived
- timeFrame
- 5 years
- description
- The outcomes were measured through follow-up visits of the patients to the out-patient clinic of our institution at 15 days, 1 month, 3 months, 6 months, 1 year, and after that, every year after the surgical treatment.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 15 Years
Show eligibility criteria text
Inclusion Criteria: * All operated patients with GIST * Positive immunohistochemistry Exclusion Criteria: * Patients with GIST not operated * Patients with GIST operated on but without immunohistochemistry
References
Publications (0)
Data not yet available
No reference posted for this study.